212 related articles for article (PubMed ID: 2220258)
1. Pyridostigmine partially restores the GH responsiveness to GHRH in normal aging.
Ghigo E; Goffi S; Arvat E; Nicolosi M; Procopio M; Bellone J; Imperiale E; Mazza E; Baracchi G; Camanni F
Acta Endocrinol (Copenh); 1990 Aug; 123(2):169-73. PubMed ID: 2220258
[TBL] [Abstract][Full Text] [Related]
2. Cholinergic receptor activation by pyridostigmine restores growth hormone (GH) responsiveness to GH-releasing hormone administration in obese subjects: evidence for hypothalamic somatostatinergic participation in the blunted GH release of obesity.
Cordido F; Casanueva FF; Dieguez C
J Clin Endocrinol Metab; 1989 Feb; 68(2):290-3. PubMed ID: 2493023
[TBL] [Abstract][Full Text] [Related]
3. Low hexarelin dose and pyridostigmine have additive effect and potentiate to the same extent the GHRH-induced GH response in man.
Arvat E; Di Vito L; Ramunni J; Gianotti L; Giordano R; Deghenghi R; Camanni F; Ghigo E
Clin Endocrinol (Oxf); 1997 Oct; 47(4):495-500. PubMed ID: 9404449
[TBL] [Abstract][Full Text] [Related]
4. Effect of potentiation of cholinergic tone by pyridostigmine on the GH response to GHRH in elderly men.
Coiro V; Volpi R; Bertoni P; Finzi G; Marcato A; Caiazza A; Colla R; Giacalone G; Rossi G; Chiodera P
Gerontology; 1992; 38(4):217-22. PubMed ID: 1358762
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone secretion in Alzheimer's disease: studies with growth hormone-releasing hormone alone and combined with pyridostigmine or arginine.
Ghigo E; Nicolosi M; Arvat E; Marcone A; Danelon F; Mucci M; Franceschi M; Smirne S; Camanni F
Dementia; 1993; 4(6):315-20. PubMed ID: 8136894
[TBL] [Abstract][Full Text] [Related]
6. The enhancing effect of pyridostigmine on the GH response to GHRH undergoes an accelerated age-related reduction in Down syndrome.
Arvat E; Gianotti L; Ragusa L; Valetto MR; Cappa M; Aimaretti G; Ramunni J; Grottoli S; Camanni F; Ghigo E
Dementia; 1996; 7(5):288-92. PubMed ID: 8872421
[TBL] [Abstract][Full Text] [Related]
7. Cholinergic control of growth hormone (GH) responses to GH-releasing hormone in insulin dependent diabetics: evidence for attenuated hypothalamic somatostatinergic tone and decreased GH autofeedback.
Ismail IS; Scanlon MF; Peters JR
Clin Endocrinol (Oxf); 1993 Feb; 38(2):149-57. PubMed ID: 8094648
[TBL] [Abstract][Full Text] [Related]
8. Activation of cholinergic tone by pyridostigmine reverses the inhibitory effect of corticotropin-releasing hormone on the growth hormone-releasing hormone-induced growth hormone secretion.
Corsello SM; Tofani A; Della Casa S; Sciuto R; Rota CA; Colasanti S; Bini A; Barini A; Barbarino A
Acta Endocrinol (Copenh); 1992 Feb; 126(2):113-6. PubMed ID: 1543015
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone (GH) responsiveness to combined administration of arginine and GH-releasing hormone does not vary with age in man.
Ghigo E; Goffi S; Nicolosi M; Arvat E; Valente F; Mazza E; Ghigo MC; Camanni F
J Clin Endocrinol Metab; 1990 Dec; 71(6):1481-5. PubMed ID: 2229304
[TBL] [Abstract][Full Text] [Related]
10. Failure of pyridostigmine to increase both basal and GHRH-induced GH secretion in the night.
Ghigo E; Arvat E; Mazza E; Mondardini A; Cappa M; Müller EE; Cammani F
Acta Endocrinol (Copenh); 1990 Jan; 122(1):37-40. PubMed ID: 2106188
[TBL] [Abstract][Full Text] [Related]
11. Effects of exogenous growth hormone pretreatment on the pituitary growth hormone response to growth hormone-releasing hormone alone or in combination with pyridostigmine in type I diabetic patients.
Giustina A; Bossoni S; Bodini C; Cimino A; Pizzocolo G; Schettino M; Wehrenberg WB
Acta Endocrinol (Copenh); 1991 Nov; 125(5):510-7. PubMed ID: 1759540
[TBL] [Abstract][Full Text] [Related]
12. Effect of enhancement of endogenous cholinergic tone with pyridostigmine on the dose-response relationships of growth hormone (GH)-releasing hormone-induced GH secretion in normal subjects.
Peñalva A; Muruais C; Casanueva FF; Dieguez C
J Clin Endocrinol Metab; 1990 Feb; 70(2):324-7. PubMed ID: 2105328
[TBL] [Abstract][Full Text] [Related]
13. Radiation and neuroregulatory control of growth hormone secretion.
Ogilvy-Stuart AL; Wallace WH; Shalet SM
Clin Endocrinol (Oxf); 1994 Aug; 41(2):163-8. PubMed ID: 7923820
[TBL] [Abstract][Full Text] [Related]
14. Effect of arginine and pyridostigmine on the GHRH-induced GH rise in obesity and Cushing's syndrome.
Procopio M; Invitti C; Maccario M; Grottoli S; Cavagnini F; Camanni F; Ghigo E
Int J Obes Relat Metab Disord; 1995 Feb; 19(2):108-12. PubMed ID: 7735336
[TBL] [Abstract][Full Text] [Related]
15. Evidence against depletion of the growth hormone (GH)-releasable pool in human primary hypothyroidism: studies with GH-releasing hormone, pyridostigmine, and arginine.
Valcavi R; Valente F; Dieguez C; Zini M; Procopio M; Portioli I; Ghigo E
J Clin Endocrinol Metab; 1993 Sep; 77(3):616-20. PubMed ID: 8103770
[TBL] [Abstract][Full Text] [Related]
16. Activation of cholinergic neurotransmission by pyridostigmine reverses the inhibitory effect of hyperglycemia on growth hormone (GH) releasing hormone-induced GH secretion in man: does acute hyperglycemia act through hypothalamic release of somatostatin?
Peñalva A; Burguera B; Casabiell X; Tresguerres JA; Dieguez C; Casanueva FF
Neuroendocrinology; 1989 May; 49(5):551-4. PubMed ID: 2566942
[TBL] [Abstract][Full Text] [Related]
17. Effect of cholinergic tone on growth hormone-releasing hormone-induced secretion of growth hormone in normal aging.
Giusti M; Marini G; Sessarego P; Peluffo F; Valenti S; Caratti C; Giordano G
Aging (Milano); 1992 Sep; 4(3):231-7. PubMed ID: 1420407
[TBL] [Abstract][Full Text] [Related]
18. Melatonin stimulates growth hormone secretion through pathways other than the growth hormone-releasing hormone.
Valcavi R; Zini M; Maestroni GJ; Conti A; Portioli I
Clin Endocrinol (Oxf); 1993 Aug; 39(2):193-9. PubMed ID: 8370132
[TBL] [Abstract][Full Text] [Related]
19. Pyridostigmine potentiates growth hormone (GH)-releasing hormone-induced GH release in both men and women.
Arvat E; Cappa M; Casanueva FF; Dieguez C; Ghigo E; Nicolosi M; Valcavi R; Zini M
J Clin Endocrinol Metab; 1993 Feb; 76(2):374-7. PubMed ID: 8432781
[TBL] [Abstract][Full Text] [Related]
20. Effect of growth hormone (GH)-releasing hormone (GHRH), atropine, pyridostigmine, or hypoglycemia on GHRP-6-induced GH secretion in man.
Peñalva A; Carballo A; Pombo M; Casanueva FF; Dieguez C
J Clin Endocrinol Metab; 1993 Jan; 76(1):168-71. PubMed ID: 8421084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
